Recombinant multi-species Amphiregulin/AREG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Amphiregulin/AREG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the epidermal growth factor family. It is an autocrine growth factor as well as a mitogen for astrocytes, Schwann cells and fibroblasts. It is related to epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha). The protein interacts with the EGF/TGF-alpha receptor to promote the growth of normal epithelial cells, and it inhibits the growth of certain aggressive carcinoma cell lines. It also functions in mammary gland, oocyte and bone tissue development. This gene is associated with a psoriasis-like skin phenotype, and is also associated with other pathological disorders, including various types of cancers and inflammatory conditions. [provided by RefSeq, Apr 2014]
The Alternative Names of target: AR,AREG,AREGB,Amphiregulin,Areg,CRDGF,Colorectum cell-derived growth factor (CRDGF),Mcub,SDGF,Sdgf

Target products collectionGo to Amphiregulin/AREG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T92834-Ag-1/ GM-Tg-hg-T92834-Ag-2 Human Amphiregulin/AREG protein Human
GM-Tg-rg-T92834-Ag-1/ GM-Tg-rg-T92834-Ag-2 Rat Amphiregulin/AREG protein Rat
GM-Tg-mg-T92834-Ag-1/ GM-Tg-mg-T92834-Ag-2 Mouse Amphiregulin/AREG protein Mouse
GM-Tg-cynog-T92834-Ag-1/ GM-Tg-cynog-T92834-Ag-2 Cynomolgus/Rhesus macaque Amphiregulin/AREG protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T92834-Ag-1/ GM-Tg-felg-T92834-Ag-2 Feline Amphiregulin/AREG protein Feline
GM-Tg-cang-T92834-Ag-1/ GM-Tg-cang-T92834-Ag-2 Canine Amphiregulin/AREG protein Canine
GM-Tg-bovg-T92834-Ag-1/ GM-Tg-bovg-T92834-Ag-2 Bovine Amphiregulin/AREG protein Bovine
GM-Tg-equg-T92834-Ag-1/ GM-Tg-equg-T92834-Ag-2 Equine Amphiregulin/AREG protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T92834-Ag-1/ GM-Tg-hg-T92834-Ag-2; GM-Tg-rg-T92834-Ag-1/ GM-Tg-rg-T92834-Ag-2;
GM-Tg-mg-T92834-Ag-1/ GM-Tg-mg-T92834-Ag-2; GM-Tg-cynog-T92834-Ag-1/ GM-Tg-cynog-T92834-Ag-2;
GM-Tg-felg-T92834-Ag-1/ GM-Tg-felg-T92834-Ag-2; GM-Tg-cang-T92834-Ag-1/ GM-Tg-cang-T92834-Ag-2;
GM-Tg-bovg-T92834-Ag-1/ GM-Tg-bovg-T92834-Ag-2; GM-Tg-equg-T92834-Ag-1/ GM-Tg-equg-T92834-Ag-2
Products Name Amphiregulin/AREG protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Amphiregulin/AREG
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Amphiregulin/AREG protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.